СТАРЕНИЕ И ГОРМОН РОСТА: ПРЕДПОЛОЖЕНИЯ И ФАКТЫ (ОБЗОР ЛИТЕРАТУРЫ)

Аннотация

Гормон роста — мощный метаболический гормон с плейотропными эффектами, который позиционируется как «источник молодости». Соматотропин обладает многообразными функциями: стимуляция роста костей, регуляция углеводного, белкового, липидного обменов, метаболической функции печени и энергетического баланса. На клеточном уровне соматотропный гормон регулирует рост клеток, дифференцировку, апоптоз и реорганизацию цитоскелета. В обзорной статье представлены результаты актуальных исследований, отражающих взаимосвязь дефицита гормона роста или резистентности к нему с развитием старения и заболеваний, ассоциированных с возрастом, а также с увеличением продолжительности жизни.

Об авторах

Список литературы

Asolkar S.V., Sivaprasad N., Deshpande A., Shah K.B., Mani R.S. Radioimmunoassay of human growth hormone and its application in pituitary dysfunction studies. J. Radioanal. Chem. 1981; 65(1-2): 297-305.

Bartke A. Somatic growth, aging, and longevity. NPJ Aging Mech Dis. 2017; 29: 3-14.

Anisimov V.N., Bartke A. The key role of growth hormone-insulin- IGF -1 signaling in aging and cancer. Crit. Rev. Oncol. Hematol. 2013; 87(3): 201-23.

Bodart G., Farhat K., Charlet-Renard C., Salvatori R., Geenen V., Martens H. The somatotrope growth hormone-releasing hormone/growth hormone/insulin-like growth factor-1 axis in immunoregulation and immunosenescence. Front. Horm. Res. 2017; 48: 147-59.

Rudman D., Feller A.G., Nagraj H.S. Gergans G.A., Lalitha P.Y., Goldberg A.F. et al. Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 1990; 323(1): 1-6.

Papadakis M.A., Grady D., Black D. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann. Intern. Med. 1996; 124(8):708-16.

Duran-Ortiz S., Brittain A.L., Kopchick J.J. The impact of growth hormone on proteomic profiles: a review of mouse and adult human studies. Clin. Proteomics. 2017; 14: 24.

François J.C., Aïd S., Chaker Z., Lacube P., Xu J., Fayad R. et al. Disrupting IGF signaling in adult mice conditions leanness, resilient energy metabolism, and high growth hormone pulses. Endocrinology. 2017; 158(7): 2269-83.

Sun L.Y., Fang Y., Patki A., Koopman J.J., Allison D.B., Hill C.M. et al. Longevity is impacted by growth hormone action during early postnatal period. Elife. 2017; 6: e24059.

De Mello-Coelho V., Cutler R.G., Bunbury A., Tammara A., Mattson M.P., Taub D.D. Age-associated alterations in the levels of cytotoxic lipid molecular species and oxidative stress in the murine thymus are reduced by growth hormone treatment. Mech. Ageing Dev. 2017; 167: 46-55.

Clemmons D.R. Growth hormone should be used only for approved indications. Clin. Endocrinol. Metab. 2014; 99(2): 409-11.

Bartke A., List E.O., Kopchick J.J. The somatotropic axis and aging: Benefits of endocrine defects. Growth Horm. IGF Res. 2016; 27: 41-5.

Bartke A. Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology. 2003; 78(4): 210-6.

Bartke A., Darcy J. GH and ageing: pitfalls and new insights. Best Pract. Res. Clin. Endocrinol. Metab. 2017; 31(1): 113-25.

Rollo C.D., Carlson J., Sawada M. Accelerated aging of giant transgenic mice is associated with elevated free radical processes. Canadian Journal of Zoology. 1996; 74: 606-20.

Darcy J., McFadden S., Bartke A. Altered structure and function of adipose tissue in long-lived mice with growth hormone-related mutations. Adipocyte. 2017; 6(2): 69-75.

Masternak M.M., Darcy J., Victoria B., Bartke A. Dwarf mice and aging. Prog. Mol. Biol. Transl. Sci. 2018; 155: 69-83.

Gesing A., Wiesenborn D., Do A., Menon V., Schneider A., Victoria B. et al. A long-lived mouse lacking both growth hormone and growth hormone receptor: a new animal model for aging studies. J. Gerontol. A Biol. Sci. Med. Sci. 2017; 72(8): 1054-61.

Corpas E., Harman S.M., Blackman M.R. Human growth hormone and human aging. Endocrine Reviews. 1993; 14: 20-39.

Fabris N., Pierpaoli W., Sorkin E. Lymphocytes, hormones and ageing. Nature. 1972; 240(5383): 557-9.

Shire J.G. Growth hormone and premature ageing. Nature. 1973; 245(5422): 215-6.

Silberberg R. Vertebral aging in hypopituitary dwarf mice. Gerontologia. 1973; 19(5): 281-94.

Darcy J., Bartke A. Functionally enhanced brown adipose tissue in Ames dwarf mice. Adipocyte. 2017; 6(1): 62-7.

Duran-Ortiz S., Noboa V., Kopchick J.J. Disruption of the GH receptor gene in adult mice and in insulin sensitive tissues. Growth Horm. IGF Res. 2018;38: 3-7.

Basu R., Qian Y., Kopchick J.J. Mechanisms in endocrinology: Lessons from growth hormone receptor gene-disrupted mice: are there benefits of endocrine defects? Eur. J. Endocrinol. 2018;178(5): R155-81.

Laron Z., Kauli R., Lapkina L., Werner H. IGF -1 deficiency, longevity and cancer protection of patients with Laron syndrome. Mutat. Res. Rev. Mutat. Res. 2017; 772: 123-33.

Jung S., Boie G., Doerr H.G., Trollmann R. Oxygen-sensitive regulation and neuroprotective effects of growth hormone-dependent growth factors during early postnatal development. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2017; 312(4): R539-48.

Aguiar-Oliveira M.H., Bartke A. Growth hormone deficiency: health and longevity. Endocr. Rev. 2018; 12: 326-33.

Reddy S.S.K., Chaiban J.T. The endocrinology of aging: a key to longevity “great expectations”. Endocr.Pract. 2017; 23(9): 1107-16.

Bartke A., Quainoo N. Impact of growth hormone-related mutations on mammalian aging. Front Genet. 2018; 9: 586.

Brown-Borg H.M., Rakoczy S.G. Catalase expression in delayed and premature aging mouse models. Exp. Gerontol. 2000; 35(2): 199-212.

Hauck S.J., Bartke A. Effects of growth hormone on hypothalamic catalase and Cu/Zn superoxide dismutase. Free Radic. Biol. Med. 2000; 28(6): 970-8.

Brown-Borg H.M., Johnson W.T., Rakoczy S.G. Expression of oxidative phosphorylation components in mitochondria of long-living Ames dwarf mice. Age (Dordr.). 2012; 34(1): 43-57.

Salmon A.B. Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stress. Am. J. Physiol. Endocrinol. Metab. 2005; 289(1): E23-9.

Tang Y., Purkayastha S., Cai D. Hypothalamic microinflammation: a common basis of metabolic syndrome and aging. Trends Neurosci. 2015; 38(1): 36-44.

Selman C. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science. 2009; 326(5949): 140-4.

Wijsman C.A. Familial longevity is marked by enhanced insulin sensitivity. Aging Cell. 2011; 10(1): 114-21.

Johnson S.C., Rabinovitch P.S., Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature. 2013; 493(7432): 338-45.

Neff F. Rapamycin extends murine lifespan but has limited effects on aging. J. Clin. Invest. 2013; 123(8): 3272-91.

Vitale G., Barbieri M., Kamenetskaya M., Paolisso G. GH/ IGF -1/insulin system in centenarians. Mech. Ageing Dev. 2017; 165: 107-14.

Sadagurski M., Cady G., Miller R.A. Anti-aging drugs reduce hypothalamic inflammation in a sex-specific manner. Aging Cell. 2017; 16(4): 652-60.

Greer K.A., Hughes L.M., Masternak M.M. Connecting serum IGF-1, body size, and age in the domestic dog. Age (Dordr). 2011; 33(3): 475-83.

Kienzle E., Moik K. A pilot study of the body weight of pure-bred client-owned adult cats. Br. J. Nutr. 2011; 106(Suppl 1): S113-5.

Brosnahan M.M., Paradis M.R. Demographic and clinical characteristics of geriatric horses: 467 cases (1989-1999). J. Am. Vet. Med. Assoc. 2003; 223(1): 93-8.

Holzenberger M. IGF-1 signaling and effects on longevity. Nestle Nutr. Workshop Ser. Pediatr. Program. 2011; 68: 237-49.

Taguchi A, Wartschow LM, White MF. Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science. 2007; 317(5836): 369-72.

Ключевые слова